Fresenius Posts Narrow Profit Miss Amid Headwinds From China

Fresenius SE reported quarterly results that narrowly missed expectations as pricing pressure in China weighed on its clinical nutrition business.

First-quarter earnings rose by 6% to €678 million ($795 million) before interest and taxes and on constant currency terms, the German company said Wednesday. That was below the €686 million average of analyst estimates compiled by Bloomberg.